NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

蛋白質結晶化·結晶分析的全球市場:2020年∼2024年

Global Protein Crystallization and Crystallography Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 959985
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
蛋白質結晶化·結晶分析的全球市場:2020年∼2024年 Global Protein Crystallization and Crystallography Market 2020-2024
出版日期: 2020年08月27日內容資訊: 英文 120 Pages
簡介

全球蛋白質結晶化·結晶分析的市場規模在2020年∼2024年間,預測將成長到9億8233萬美元,在預測期間內預計將以9%的年複合成長率推移。市場成長的主要因素有推動蛋白質治療需求的疾病發生率增加,藥物研發的投資增加,及農業上蛋白質工程的潛在可能性增加。

本報告提供蛋白質結晶化·結晶分析市場調查,提供市場概要,市場成長要素及阻礙因素分析,各產品·各終端用戶·各地區的市場規模的變化與預測,供應商分析,市場機會等全面性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:2019年-2024年的預測

波特的五力分析

各產品的市場區隔

  • 市場·市場區隔
  • 每個產品的比較
  • 試劑-市場規模與預測(2019年-2024年)
  • 設備-市場規模與預測(2019年-2024年)
  • 各產品的市場機會

各終端用戶市場區隔

  • 市場·市場區隔
  • 各終端用戶比較
  • 製藥-市場規模與預測(2019年-2024年)
  • 生物科技-(2019年-2024年)年貨市場規模與預測
  • 其他終端用戶-市場規模與預測(2019年-2024年)
  • 各終端用戶市場機會

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美 -市場規模與預測(2019年-2024年)
  • 歐洲-市場規模與預測(2019年-2024年)
  • 亞洲-市場規模與預測(2019年-2024年)
  • 其他地區-市場規模與預測(2019年-2024年)
  • 主要國家
  • 地區的市場機會
  • 市場成長要素
  • 市場課題
  • 市場趨勢

業者情勢

  • 概況
  • 業者情勢
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Bio-Rad Laboratories Inc.
  • Bruker Corp.
  • Corning Inc.
  • Fluidigm Corp.
  • Jena Bioscience GmbH
  • Merck KGaA
  • PerkinElmer Inc.
  • Rigaku Corp.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

附錄

目錄
Product Code: IRTNTR44347

Technavio has been monitoring the protein crystallization and crystallography market and it is poised to grow by $ 982.33 mn during 2020-2024 progressing at a CAGR of 9% during the forecast period. Our reports on protein crystallization and crystallography market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidences of diseases propelling the demand for novel protein therapeutics, rising investments in drug discovery, and growing potential of protein engineering in agriculture. In addition, increasing incidences of diseases propelling the demand for novel protein therapeutics is anticipated to boost the growth of the market as well.

The protein crystallization and crystallography market analysis include product segment, end-user segment, and geographical landscapes

Technavio's ‘protein crystallization and crystallography market ’ is segmented as below:

By Product:

  • Reagents
  • Instruments
  • End-user
  • Pharma
  • Biotech
  • Other end-users

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the emergence of automated protein crystallization as one of the prime reasons driving the protein crystallization and crystallography market growth during the next few years. Also, the introduction of advanced protein crystallization facilities and outsourcing of drug discovery process will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our protein crystallization and crystallography market cover the following areas:

  • Protein crystallization and crystallography market sizing
  • Protein crystallization and crystallography market forecast
  • Protein crystallization and crystallography market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading protein crystallization and crystallography market vendors that include Bio-Rad Laboratories Inc., Bruker Corp., Corning Inc., Fluidigm Corp., Jena Bioscience GmbH, Merck KGaA, PerkinElmer Inc., Rigaku Corp., Tecan Group Ltd., and Thermo Fisher Scientific Inc.. Also, the protein crystallization and crystallography market analysis report include information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Reagents - Market size and forecast 2019-2024
  • Instruments - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by End-user

  • Market segments
  • Comparison by End user
  • Pharma - Market size and forecast 2019-2024
  • Biotech - Market size and forecast 2019-2024
  • Other end-users - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bio-Rad Laboratories Inc.
  • Bruker Corp.
  • Corning Inc.
  • Fluidigm Corp.
  • Jena Bioscience GmbH
  • Merck KGaA
  • PerkinElmer Inc.
  • Rigaku Corp.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Key Finding 9
  • 9: Parent market
  • 10: Market characteristics
  • 11: Offerings of vendors included in the market definition
  • 12: Market segments
  • 13: Global - Market size and forecast 2019 - 2024 ($ million)
  • 14: Global market: Year-over-year growth 2019 - 2024 (%)
  • 15: Five forces analysis 2019 & 2024
  • 16: Bargaining power of buyers
  • 17: Bargaining power of suppliers
  • 18: Threat of new entrants
  • 19: Threat of substitutes
  • 20: Threat of rivalry
  • 21: Market condition - Five forces 2019
  • 22: Product - Market share 2019-2024 (%)
  • 23: Comparison by Product
  • 24: Reagents - Market size and forecast 2019-2024 ($ million)
  • 25: Reagents - Year-over-year growth 2019-2024 (%)
  • 26: Instruments - Market size and forecast 2019-2024 ($ million)
  • 27: Instruments - Year-over-year growth 2019-2024 (%)
  • 28: Market opportunity by Product
  • 29: End user - Market share 2019-2024 (%)
  • 30: Comparison by End user
  • 31: Pharma - Market size and forecast 2019-2024 ($ million)
  • 32: Pharma - Year-over-year growth 2019-2024 (%)
  • 33: Biotech - Market size and forecast 2019-2024 ($ million)
  • 34: Biotech - Year-over-year growth 2019-2024 (%)
  • 35: Other end-users - Market size and forecast 2019-2024 ($ million)
  • 36: Other end-users - Year-over-year growth 2019-2024 (%)
  • 37: Market opportunity by End user
  • 38: Customer landscape
  • 39: Market share by geography 2019-2024 (%)
  • 40: Geographic comparison
  • 41: North America - Market size and forecast 2019-2024 ($ million)
  • 42: North America - Year-over-year growth 2019-2024 (%)
  • 43: Europe - Market size and forecast 2019-2024 ($ million)
  • 44: Europe - Year-over-year growth 2019-2024 (%)
  • 45: Asia - Market size and forecast 2019-2024 ($ million)
  • 46: Asia - Year-over-year growth 2019-2024 (%)
  • 47: ROW - Market size and forecast 2019-2024 ($ million)
  • 48: ROW - Year-over-year growth 2019-2024 (%)
  • 49: Key leading countries
  • 50: Market opportunity by geography ($ million)
  • 51: Impact of drivers and challenges
  • 52: Vendor landscape
  • 53: Landscape disruption
  • 54: Industry risks
  • 55: Vendors covered
  • 56: Market positioning of vendors
  • 57: Bio-Rad Laboratories Inc. - Overview
  • 58: Bio-Rad Laboratories Inc. - Business segments
  • 59: Bio-Rad Laboratories Inc. - Key offerings
  • 60: Bio-Rad Laboratories Inc. - Key customers
  • 61: Bio-Rad Laboratories Inc. - Segment focus
  • 62: Bruker Corp. - Overview
  • 63: Bruker Corp. - Business segments
  • 64: Bruker Corp. - Key offerings
  • 65: Bruker Corp. - Key customers
  • 66: Bruker Corp. - Segment focus
  • 67: Corning Inc. - Overview
  • 68: Corning Inc. - Business segments
  • 69: Corning Inc. - Key offerings
  • 70: Corning Inc. - Key customers
  • 71: Corning Inc. - Segment focus
  • 72: Fluidigm Corp. - Overview
  • 73: Fluidigm Corp. - Business segments
  • 74: Fluidigm Corp. - Key offerings
  • 75: Fluidigm Corp. - Key customers
  • 76: Fluidigm Corp. - Segment focus
  • 77: Jena Bioscience GmbH - Overview
  • 78: Jena Bioscience GmbH - Product and service
  • 79: Jena Bioscience GmbH - Key offerings
  • 80: Jena Bioscience GmbH - Key customers
  • 81: Jena Bioscience GmbH - Segment focus
  • 82: Merck KGaA - Overview
  • 83: Merck KGaA - Business segments
  • 84: Merck KGaA - Key offerings
  • 85: Merck KGaA - Key customers
  • 86: Merck KGaA - Segment focus
  • 87: PerkinElmer Inc. - Overview
  • 88: PerkinElmer Inc. - Business segments
  • 89: PerkinElmer Inc. - Key offerings
  • 90: PerkinElmer Inc. - Key customers
  • 91: PerkinElmer Inc. - Segment focus
  • 92: Rigaku Corp. - Overview
  • 93: Rigaku Corp. - Product and service
  • 94: Rigaku Corp. - Key offerings
  • 95: Rigaku Corp. - Key customers
  • 96: Rigaku Corp. - Segment focus
  • 97: Tecan Group Ltd. - Overview
  • 98: Tecan Group Ltd. - Product and service
  • 99: Tecan Group Ltd. - Key offerings
  • 100: Tecan Group Ltd. - Key customers
  • 101: Tecan Group Ltd. - Segment focus
  • 102: Thermo Fisher Scientific Inc. - Overview
  • 103: Thermo Fisher Scientific Inc. - Business segments
  • 104: Thermo Fisher Scientific Inc. - Key offerings
  • 105: Thermo Fisher Scientific Inc. - Key customers
  • 106: Thermo Fisher Scientific Inc. - Segment focus
  • 107: Currency conversion rates for US$
  • 108: Research Methodology
  • 109: Validation techniques employed for market sizing
  • 110: Information sources
  • 111: List of abbreviations